Literature DB >> 12060438

Accuracy of transrectal ultrasound guided prostate biopsy: histopathological correlation to matched prostatectomy specimens.

Kamil Cam1, Selcuk Yucel, Levent Turkeri, Atif Akdas.   

Abstract

BACKGROUND: The Gleason grading system is currently the world's most commonly used histological system for prostate cancer. It provides significant information about the prognosis. Therefore, Gleason score is accepted as an important factor in therapeutic decision-making for prostate cancer. This retrospective study assessed the correlation of transrectal ultrasound (TRUS) guided biopsy and radical prostatectomy specimens in terms of Gleason scores.
METHODS: We reviewed the records of 103 patients who underwent radical prostatectomy due to clinically localized prostate cancer. The Gleason scores of the TRUS biopsies were compared with the respective Gleason scores of surgical specimen.
RESULTS: In 28.7% of cases, the TRUS biopsy score was the same as that of the radical prostatectomy specimen. The most significant discordance was the upgrading of well-differentiated tumors after surgery in 71.7% of cases. However, in 81.8% of cases with high Gleason score on TRUS, biopsy was correlated with poorly differentiated tumor after surgery.
CONCLUSIONS: Well-differentiated tumors on TRUS biopsy did not correlate with the grades of final pathology in the majority of cases; however, a high Gleason score on TRUS biopsy usually indicated a poorly differentiated tumor on prostatectomy specimen. Therefore, the treatment algorithms for particularly well-differentiated tumors should not be deduced from biopsy histology alone.

Entities:  

Mesh:

Year:  2002        PMID: 12060438     DOI: 10.1046/j.1442-2042.2002.00456.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  9 in total

1.  Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate.

Authors:  Christine M Fisher; Patricia Troncoso; David A Swanson; Mark F Munsell; Deborah A Kuban; Andrew K Lee; Shih-Fan Yeh; Steven J Frank
Journal:  Brachytherapy       Date:  2012-06-21       Impact factor: 2.362

2.  The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.

Authors:  Al B Barqawi; Ruslan Turcanu; Eduard J Gamito; Scott M Lucia; Colin I O'Donnell; E David Crawford; David D La Rosa; Francisco G La Rosa
Journal:  Int J Clin Exp Pathol       Date:  2011-06-12

3.  Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6.

Authors:  Vikas Mehta; Kevin Rycyna; Bart M M Baesens; Güliz A Barkan; Gladell P Paner; Robert C Flanigan; Eva M Wojcik; Girish Venkataraman
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29

4.  Clinical-pathologic correlation between transperineal mapping biopsies of the prostate and three-dimensional reconstruction of prostatectomy specimens.

Authors:  E David Crawford; Kyle O Rove; Al B Barqawi; Paul D Maroni; Priya N Werahera; Craig A Baer; Hari K Koul; Cory A Rove; M Scott Lucia; Francisco G La Rosa
Journal:  Prostate       Date:  2012-11-20       Impact factor: 4.104

5.  Frequency and determinants of disagreement and error in gleason scores: a population-based study of prostate cancer.

Authors:  Michael Goodman; Kevin C Ward; Adeboye O Osunkoya; Milton W Datta; Daniel Luthringer; Andrew N Young; Katerina Marks; Vaunita Cohen; Jan C Kennedy; Michael J Haber; Mahul B Amin
Journal:  Prostate       Date:  2012-01-06       Impact factor: 4.104

6.  Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer.

Authors:  Kevin Martell; Hans Chung; Gerard Morton; Danny Vesprini; Chia-Lin Tseng; Ewa Szumacher; Patrick Cheung; Will Chu; Stanley Liu; Andrew Loblaw
Journal:  Can Urol Assoc J       Date:  2022-08       Impact factor: 2.052

Review 7.  Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.

Authors:  Lizhi Liu; Zhiqiang Tian; Zhenfeng Zhang; Baowei Fei
Journal:  Acad Radiol       Date:  2016-04-25       Impact factor: 3.173

8.  Clinically low-risk prostate cancer: evaluation with transrectal doppler ultrasound and functional magnetic resonance imaging.

Authors:  Maria Inês Novis; Ronaldo Hueb Baroni; Luciana Mendes de Oliveira Cerri; Romulo Loss Mattedi; Carlos Alberto Buchpiguel
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.

Authors:  Renan A Pereira; Roberto S Costa; Valdair F Muglia; Fábio Franca Silva; Joyce S Lajes; Rodolfo B Dos Reis; Gyl Eb Silva
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.